Page 32 - Gates-AnnualReport-2016
P. 32
GATES BIOMANUFACTURING FACILITY
Gates Biomanufacturing Facility staff (BACK ROW UPPER STAIRS, left to right) Jamie Bunker, Jordan Krause, Tom Street, Gabe Orosco, Frances Brostrom, Matt Brenton, Jackie Nelson (FRONT ROW, left to right) Dante Merrill, Mitchell Fraller, Sonja Giguere, Tom Payne, Dr. Roop, Sadhna Mehra, Brittany Robinson, Abitha Jacobs, Deepa Vadakan, Paul Lemaire, Tim Gardner, Jessica Freeman, Matt Seefeldt, and Laura Titter
This year was the first full year of operations for the Gates Biomanufacturing Facility. With over $1.3 million in service revenues generated from six commercial customers and three Anschutz Medical Campus laboratories, we exceeded our revenue forecast. In order to meet the expanding needs of our clients, we also increased our team of experienced laboratory technicians and quality managers from 10 at the beginning of the year to 21 by December 2016.
In August 2016, we delivered our first clinical grade material to an early-stage company that is developing a unique protein- based biologic, which enhances the engraftment of hematopoietic stem cells during transplantation. The company expects to use the material we produced for a human clinical trial in 2017.
32 Gates Center for Regenerative Medicine
